Clicky

PolyPeptide Group AG(0AAJ)

Description: PolyPeptide Group AG operate as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of peptide-based therapies for metabolic disorders, including the GLP-1 receptor agonist drugs for the treatment of type 2 diabetes, obesity, and other co-morbidities, as well as oncology, hormonal disorders, neurology, ophthalmology, cardiovascular, and gastrointestinal applications. It also provides peptides for cosmetics; and individualized peptide therapeutics. The company was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.


Keywords:

Home Page: www.polypeptide.com

0AAJ Technical Analysis

Neuhofstrasse 24
Baar, 6340
Switzerland
Phone: 41 435 020 580


Officers

Name Title
Mr. Juan Jose Gonzalez Chief Executive Officer
Mr. Marc Augustin Chief Financial Officer
Mr. Jens Fricke Director of Global Operations
Rene Vestergaard Director of Corporate Finance
Mr. Olivier Ludemann-Hombourger Director Global Innovation & Technology
Ms. Christina Del Vecchio General Counsel & Corporate Secretary
Ms. Monika Casanova Chief Human Resources Officer
Christophe Chevalier Head of Technical Department - Braine
Krister Svard Chief Information Security Officer & Global IT Services VC
Rebecca Weil Head of Internal Audit

Exchange: LSE

Country: GB : United Kingdom of Great Britain and Northern Ireland

Currency: British Pound (£)

Forward PE: 0
Trailing PE: 0.1848
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 1277
Back to stocks